Reports from Zhejiang University Advance Knowledge in Multiple Myeloma (Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study)

Press/Media: Research

PeriodDec 24 2024

Media coverage

1

Media coverage

  • TitleReports from Zhejiang University Advance Knowledge in Multiple Myeloma (Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date24/12/24
    PersonsYang Yang
View all 1
View less